<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Universal American Corp</title>
	<atom:link href="http://www.stockbloghub.com/tag/universal-american-corp/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Thu, 24 May 2012 23:16:35 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(CVS) CVS Caremark Remains Neutral</title>
		<link>http://www.stockbloghub.com/2012/03/02/cvs-cvs-caremark-remains-neutral/94056</link>
		<comments>http://www.stockbloghub.com/2012/03/02/cvs-cvs-caremark-remains-neutral/94056#comments</comments>
		<pubDate>Fri, 02 Mar 2012 14:43:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=94056</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $46.00. CVS reported adjusted EPS of 89 cents in the fourth quarter of 2011 in line with the Zacks Consensus Estimate and 12.6% higher than the year-ago quarter. For the full year, adjusted EPS rose 4.5% (5.9% excluding 2010 tax benefit) to $2.80, also matching the Zacks Consensus Estimate. CVS is gradually witnessing strong performance in the field of Pharmacy Services. After a sluggish phase, the company has exhibited improved performance in this segment for the fourth consecutive quarter and has started off the 2012 selling season on a positive note. With 90% of the contract renewals scheduled for 2012 already complete at the end of fiscal 2011, CVS’s retention rate was as high ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/03/02/cvs-cvs-caremark-remains-neutral/94056/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WLP) These Healthcare Insurance Stocks Are Ready to Rise</title>
		<link>http://www.stockbloghub.com/2012/01/31/wlp-these-healthcare-insurance-stocks-are-ready-to-rise/28975</link>
		<comments>http://www.stockbloghub.com/2012/01/31/wlp-these-healthcare-insurance-stocks-are-ready-to-rise/28975#comments</comments>
		<pubDate>Tue, 31 Jan 2012 16:47:13 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AEE]]></category>
		<category><![CDATA[Ameren Corporation]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[Coventry Health Care Inc.]]></category>
		<category><![CDATA[CVH]]></category>
		<category><![CDATA[HealthSpring Inc]]></category>
		<category><![CDATA[HS]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[PCG]]></category>
		<category><![CDATA[PEG]]></category>
		<category><![CDATA[PG & E Corporation]]></category>
		<category><![CDATA[Public Service Enterprise Group Inc]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=28975</guid>
		<description><![CDATA[by Marc Lichtenfeld, Healthcare Expert Wednesday, February 24, 2010: Issue #1203 Healthcare Reform 2.0 is here – this time without as much pork. Good thing, too. Pork is loaded with cholesterol, which increases heart disease, healthcare costs and… well, you get the idea. The President released his revised plan for healthcare reform earlier this week. And while the new proposal is similar to the Senate’s on Christmas Eve, it eliminates some of the pork to Nebraska and other special interests. I’m not going to politicize, though. I’ll leave that to the wackos on talk radio and cable “news” programs. I’ll just focus on what the plan means to health insurers – and investors. Stemming the Tide of Health Insurance Premium Hikes Obama has stated that his proposal is an opening ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2012/01/31/wlp-these-healthcare-insurance-stocks-are-ready-to-rise/28975/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Corporation to Attend Healthcare Conference</title>
		<link>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481</link>
		<comments>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481#comments</comments>
		<pubDate>Fri, 30 Dec 2011 18:17:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=89481</guid>
		<description><![CDATA[The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) has decided to participate in the annual JP Morgan Healthcare Conference scheduled on January 10, 2012. The company will be represented by its president and CEO, Mr. Larry Merlo, at the conference. Currently, CVS Caremark is ranked among the top three pharmacy benefit managers (PBM) in the US. The other big players in this chart are Express Scripts (ESRX) and Medco Health Solutions (MHS). Together these three companies control roughly 50% of the market by covering approximately 240 million prescription drug consumers annually. Rhode Island-based CVS Caremark is a combination of a PBM as well as retail drug chain. In terms of contractual arrangements with large plan sponsors, CVS Caremark holds a leading ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/12/30/cvs-cvs-caremark-corporation-to-attend-healthcare-conference/89481/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark  Launches New Pharmacy Advisor Program</title>
		<link>http://www.stockbloghub.com/2011/11/14/cvs-cvs-caremark-launches-new-pharmacy-advisor-program/86901</link>
		<comments>http://www.stockbloghub.com/2011/11/14/cvs-cvs-caremark-launches-new-pharmacy-advisor-program/86901#comments</comments>
		<pubDate>Mon, 14 Nov 2011 18:00:58 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86901</guid>
		<description><![CDATA[CVS Caremark (CVS) recently launched a new Pharmacy Advisor program to help treat chronic cardiovascular illness. The Pharmacy Advisor for chronic cardiovascular care will primarily focus on medication adherence for persistent illnesses such as high blood pressure, high cholesterol, coronary artery disease (CAD) and congestive heart failure (CHF). It has been noted that high blood pressure single-handedly affects one out of three adults, with the health care system costing roughly $76 billion annually. This program is based on the research done by the company along with Harvard University, Brigham and Women&#8217;s Hospital. The research, published in a healthcare journal in January, found that proper medication adherence can save nearly $4,000 hypertension patients, $1,200 high cholesterol patients and $8,000 CHF patients annually. We are encouraged by the improved performance of CVS ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/14/cvs-cvs-caremark-launches-new-pharmacy-advisor-program/86901/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Posts a Strong Quarter</title>
		<link>http://www.stockbloghub.com/2011/11/06/cvs-cvs-caremark-posts-a-strong-quarter/86465</link>
		<comments>http://www.stockbloghub.com/2011/11/06/cvs-cvs-caremark-posts-a-strong-quarter/86465#comments</comments>
		<pubDate>Sun, 06 Nov 2011 20:15:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86465</guid>
		<description><![CDATA[CVS Caremark (CVS) reported third quarter 2011 EPS of 65 cents, 8.3% up year over year. However, after excluding the impact of certain one-time items, adjusted EPS came in at 70 cents, surpassing the Zacks Consensus Estimate of 67 cents and 9.3% higher than the year-ago quarter adjusted EPS. Net revenue increased 12.5% year over year to $26.7 billion, almost in line with the Zacks Consensus Estimate. The Pharmacy Services segment posted a robust 25.8% increase in revenues to $14.8 billion during the reported quarter. The significant growth was primarily on the back of the long-term contract with Aetna (AET) as well as the acquisition of the Medicare Part D business of Universal American Corp. (UAM). These contracts, combined with an increase in covered lives in the company’s existing Medicare ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/06/cvs-cvs-caremark-posts-a-strong-quarter/86465/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891</link>
		<comments>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891#comments</comments>
		<pubDate>Sun, 11 Sep 2011 16:43:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82891</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $38.00. CVS reported an adjusted EPS of 65 cents in the second quarter of 2011, surpassing the Zacks Consensus Estimate by a penny but meeting the year-ago quarter’s adjusted EPS. After a period of sluggish performance, CVS’ Pharmacy Benefit Management (PBM) segment grew for the second consecutive quarter. During the quarter, this segment recorded a robust 23.2% year-over-year increase in revenues to reach $14.6 billion. The year-over upside was primarily driven by a 12-year contract with Aetna (AET), under which CVS provides PBM services to Aetna customers as well as the new acquisition of the Medicare Part D business of Universal American Corp (UAM). The company is also confident of achieving further growth in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/11/cvs-cvs-caremark-analyst-maintains-shares-at-neutral/82891/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Beats Earnings by a Penny &#8211; Guidance Narrowed</title>
		<link>http://www.stockbloghub.com/2011/08/05/cvs-cvs-caremark-beats-earnings-by-a-penny-guidance-narrowed/80662</link>
		<comments>http://www.stockbloghub.com/2011/08/05/cvs-cvs-caremark-beats-earnings-by-a-penny-guidance-narrowed/80662#comments</comments>
		<pubDate>Fri, 05 Aug 2011 17:43:56 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=80662</guid>
		<description><![CDATA[CVS Caremark (CVS) reported second quarter 2011 EPS of 60 cents, at par with the year-ago quarter earnings. However, after excluding the impact of certain one-time items, adjusted earnings per share came in at 65 cents, surpassing the Zacks Consensus Estimate by a penny but meeting the year-ago quarter’s adjusted earnings. Net revenues increased 10.9% year over year to $26.6 billion, in line with the Zacks Consensus Estimate. The Pharmacy Services segment recorded a robust 23.2% increase in revenues in the quarter to $14.6 billion. The significant growth was primarily driven by the long-term contract with Aetna (AET) as well as the new acquisition of the Medicare Part D business of Universal American Corp. (UAM). These contracts, combined with an increase in covered lives in the company’s existing Medicare Part ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/08/05/cvs-cvs-caremark-beats-earnings-by-a-penny-guidance-narrowed/80662/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CVS) CVS Caremark Analyst Maintains Neutral on Shares</title>
		<link>http://www.stockbloghub.com/2011/06/04/cvs-cvs-caremark-analyst-maintains-neutral-on-shares/75294</link>
		<comments>http://www.stockbloghub.com/2011/06/04/cvs-cvs-caremark-analyst-maintains-neutral-on-shares/75294#comments</comments>
		<pubDate>Sun, 05 Jun 2011 04:20:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[FEP]]></category>
		<category><![CDATA[Franklin Electronic Publishers Inc]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[Pacific Booker Minerals Inc.]]></category>
		<category><![CDATA[PBM]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=75294</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $41.00. CVS Caremark reported an adjusted EPS of 57 cents in the first quarter of 2011, beating the Zacks Consensus Estimate of 55 cents but trailing the year-ago quarter’s adjusted EPS of 60 cents. After sluggish performance in past several quarters, the Pharmacy Benefit Management (PBM) business of CVS registered a robust 18.4% year over year increase during the quarter to reach $14 billion. The significant upside in revenue was primarily attributed to the 12-year contract with Aetna (AET), under which CVS provides PBM services to Aetna customers. We are encouraged by the company’s initiative for further focus on its key-growth areas under the PBM segment including the acquisition of Universal American&#8216;s (UAM) Medicare ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/04/cvs-cvs-caremark-analyst-maintains-neutral-on-shares/75294/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MHS) Medco Analyst Maintains Shares at Neutral</title>
		<link>http://www.stockbloghub.com/2011/05/27/mhs-medco-analyst-maintains-shares-at-neutral/74087</link>
		<comments>http://www.stockbloghub.com/2011/05/27/mhs-medco-analyst-maintains-shares-at-neutral/74087#comments</comments>
		<pubDate>Sat, 28 May 2011 04:20:55 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[E-TRACS UBS Bloomberg CMCI Livestock ETN]]></category>
		<category><![CDATA[MedcoHealth Solutions Inc.]]></category>
		<category><![CDATA[MHS]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[UBC]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>
		<category><![CDATA[Universal American Corp]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=74087</guid>
		<description><![CDATA[Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $67.00. Medco reported an adjusted EPS of 91 cents in the first quarter of fiscal 2011, beating both the Zacks Consensus Estimate of 88 cents and the year-ago EPS of 76 cents. Revenues increased 4.3% year over year to $17.0 billion in the quarter primarily driven by contributions from significant client wins as well as higher prices charged on branded drugs, partially offset by higher volumes of lower-priced generic drugs. However, revenues marginally missed the Zacks Consensus Estimate of $17.1 billion. The United BioSource (UBC) acquisition in September 2010 combined with the expansion of client base at Medicare Part D services resulted in a stupendous 57.5% increase in Medco’s service revenues. In the reported quarter, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/27/mhs-medco-analyst-maintains-shares-at-neutral/74087/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BAC) Stock Market News for Janurary 3, 2011 &#8211; Market News</title>
		<link>http://www.stockbloghub.com/2011/01/03/bac-stock-market-news-for-jan-3-2011-market-news/64370</link>
		<comments>http://www.stockbloghub.com/2011/01/03/bac-stock-market-news-for-jan-3-2011-market-news/64370#comments</comments>
		<pubDate>Mon, 03 Jan 2011 15:36:04 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Money Center Banks]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[F5 Networks Inc.]]></category>
		<category><![CDATA[FFIV]]></category>
		<category><![CDATA[IMAX]]></category>
		<category><![CDATA[IMAX Corporation]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[Marshall & Ilsley Corporation]]></category>
		<category><![CDATA[MI]]></category>
		<category><![CDATA[Netflix Inc.]]></category>
		<category><![CDATA[NFLX]]></category>
		<category><![CDATA[Regions Financial Corporation]]></category>
		<category><![CDATA[RF]]></category>
		<category><![CDATA[SNE]]></category>
		<category><![CDATA[Sony Corporation]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[Wells Fargo & Company]]></category>
		<category><![CDATA[WFC]]></category>
		<category><![CDATA[ZION]]></category>
		<category><![CDATA[Zions BanCorporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=64370</guid>
		<description><![CDATA[Investors mostly stayed away from the Street on Friday, being New Year’s Eve and markets closed largely mixed. This was also one of the lightest volume trade days of the year. Though, apart from the Dow, certain benchmarks shed a few points on the closing day, the markets posted an optimistic picture at the year end. This was the second consecutive year that markets moved up. In addition, the benchmarks also posted double-digit growth for the year. On Friday, the Dow Jones Industrial Average (DJIA) was up 0.07% and closed at 11,577.51. The S&#38;P 500 was down 0.02% and closed at 1,257.64 and the Nasdaq ended the day at 2,652.87, down 0.38%. The CBOE Volatility Index (VIX) rose to 18. On the New York Stock Exchange, volumes were expectedly dry ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/03/bac-stock-market-news-for-jan-3-2011-market-news/64370/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(UNH) Health Care Review and Outlook &#8211; September 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/09/17/unh-health-care-review-and-outlook-september-2010-industry-outlook/52020</link>
		<comments>http://www.stockbloghub.com/2010/09/17/unh-health-care-review-and-outlook-september-2010-industry-outlook/52020#comments</comments>
		<pubDate>Fri, 17 Sep 2010 15:11:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[HealthSpring Inc]]></category>
		<category><![CDATA[HS]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=52020</guid>
		<description><![CDATA[The health care industry is currently undergoing a period of tremendous uncertainty due to the implications of the recent Health Care Reform Act &#8212; named the PPACA &#8212; after it becomes fully effective. Why was the reform enacted? Health care costs, which have risen rapidly in real terms in the last few decades, have strained state and federal budgets. The entire health care sector accounts for roughly 17% of the U.S. GDP, up from 5.2% in 1960. Further growth in health care costs remains a  key risk to the long-term fiscal health of the state and federal governments. This legislation attempts to address this issue. An increasing number of people were falling out of the health insurance coverage due to rising premium prices, limiting access to health care. The legislation, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/09/17/unh-health-care-review-and-outlook-september-2010-industry-outlook/52020/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AIG) Insurance Industry Stock Update &#8211; August 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/08/03/aig-insurance-industry-stock-update-august-2010-industry-outlook/46303</link>
		<comments>http://www.stockbloghub.com/2010/08/03/aig-insurance-industry-stock-update-august-2010-industry-outlook/46303#comments</comments>
		<pubDate>Tue, 03 Aug 2010 20:40:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Property & Casualty Insurance]]></category>
		<category><![CDATA[AFL]]></category>
		<category><![CDATA[AFLAC Inc.]]></category>
		<category><![CDATA[AIG]]></category>
		<category><![CDATA[ALL]]></category>
		<category><![CDATA[Allstate Corporation]]></category>
		<category><![CDATA[American International Group Inc]]></category>
		<category><![CDATA[Ameriprise Financial Inc.]]></category>
		<category><![CDATA[AMP]]></category>
		<category><![CDATA[EIG]]></category>
		<category><![CDATA[Employers Holdings]]></category>
		<category><![CDATA[Hartford Financial Services Group Inc]]></category>
		<category><![CDATA[HIG]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[LNC]]></category>
		<category><![CDATA[PFG]]></category>
		<category><![CDATA[PRU]]></category>
		<category><![CDATA[Prudential Financial Inc.]]></category>
		<category><![CDATA[SFG]]></category>
		<category><![CDATA[StanCorp Financial Group Inc.]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Unitrin Inc.]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[UTR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=46303</guid>
		<description><![CDATA[After enduring stress with respect to pricing pressure and reduced insured exposure through mid-2009, the overall health of the U.S. insurance industry has improved to a great extent in 2010. Though the market turmoil forced many companies to take immense write-downs, the worst of the crisis appears to be now behind us. The soft market conditions, along with legislative changes, remain the chief causes for concern for the overall industry at this point. The industry continues to be challenged by the regulatory uncertainties and massive health care restructuring. Though there are signs of economic recovery, its sluggish pace is expected to continue at least through the remainder of 2010. Also, structural economies of scale have pushed the industry toward consolidation. While enormous financial support from the government helped rescue American ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/03/aig-insurance-industry-stock-update-august-2010-industry-outlook/46303/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AIG) Insurance Industry Stock Update &#8211; February 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/02/08/aig-insurance-industry-stock-update-february-2010-industry-outlook/27383</link>
		<comments>http://www.stockbloghub.com/2010/02/08/aig-insurance-industry-stock-update-february-2010-industry-outlook/27383#comments</comments>
		<pubDate>Tue, 09 Feb 2010 03:20:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[Property & Casualty Insurance]]></category>
		<category><![CDATA[AHL]]></category>
		<category><![CDATA[AIG]]></category>
		<category><![CDATA[ALL]]></category>
		<category><![CDATA[Allied World Assurance Company Holdings Limited]]></category>
		<category><![CDATA[Allstate Corporation]]></category>
		<category><![CDATA[American International Group Inc]]></category>
		<category><![CDATA[Ameriprise Financial Inc.]]></category>
		<category><![CDATA[AMP]]></category>
		<category><![CDATA[Aspen Insurance Holdings Limited]]></category>
		<category><![CDATA[AWH]]></category>
		<category><![CDATA[AXA]]></category>
		<category><![CDATA[CNO]]></category>
		<category><![CDATA[Conseco Inc.]]></category>
		<category><![CDATA[EMC Insurance Group Inc.]]></category>
		<category><![CDATA[EMCI]]></category>
		<category><![CDATA[Enstar Group Limited]]></category>
		<category><![CDATA[ESGR]]></category>
		<category><![CDATA[Everest Re Group Limited]]></category>
		<category><![CDATA[FBL Financial Group Inc.]]></category>
		<category><![CDATA[FFG]]></category>
		<category><![CDATA[GLRE]]></category>
		<category><![CDATA[Greenlight Capital Re Limited]]></category>
		<category><![CDATA[Hartford Financial Services Group Inc]]></category>
		<category><![CDATA[HIG]]></category>
		<category><![CDATA[Infinity Property and Casualty Corporation]]></category>
		<category><![CDATA[IPCC]]></category>
		<category><![CDATA[LNC]]></category>
		<category><![CDATA[Manulife Financial Corporation]]></category>
		<category><![CDATA[Max Capital Group Limited]]></category>
		<category><![CDATA[Mercer Insurance Group Inc.]]></category>
		<category><![CDATA[MFC]]></category>
		<category><![CDATA[MIGP]]></category>
		<category><![CDATA[MXGL]]></category>
		<category><![CDATA[PartnerRe Limited]]></category>
		<category><![CDATA[PFG]]></category>
		<category><![CDATA[Phoenix Companies Inc.]]></category>
		<category><![CDATA[PNX]]></category>
		<category><![CDATA[PRE]]></category>
		<category><![CDATA[PRU]]></category>
		<category><![CDATA[Prudential Financial Inc.]]></category>
		<category><![CDATA[Prudential plc]]></category>
		<category><![CDATA[PUK]]></category>
		<category><![CDATA[RE]]></category>
		<category><![CDATA[RenaissanceRe Holdings Limited]]></category>
		<category><![CDATA[RNR]]></category>
		<category><![CDATA[UAM]]></category>
		<category><![CDATA[Unitrin Inc.]]></category>
		<category><![CDATA[Universal American Corp]]></category>
		<category><![CDATA[UTR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=27383</guid>
		<description><![CDATA[The turmoil in the financial markets has created a highly challenging environment for the U.S. insurance industry, forcing many companies to take immense write-downs. This trend is expected to continue at least through the first half of 2010, though there are some early signs of an economic recovery. Also, structural economies of scale have pushed the industry toward consolidation. While enormous financial support from the government rescued AIG (AIG) from collapse, many other firms remain under tremendous pressure or have fallen by the wayside. Competition within the segments of the industry has reduced, which is consolidating through mergers and acquisitions. This has increased the market shares of the largest firms. We expect static growth with persistent soft market conditions and an ongoing market crisis, resulting in further consolidation in the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/08/aig-insurance-industry-stock-update-february-2010-industry-outlook/27383/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

